Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist

D. De Ruysscher (Maastricht, Netherlands)

Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Session: PG1 Lung cancer: the key multidisciplinary approach
Session type: Postgraduate Course
Number: 90
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. De Ruysscher (Maastricht, Netherlands). Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist. International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Approaches in patients with locally advanced NSCLC: a surgeon's perspective
Source: Eur Respir Monogr 2015; 68: 167-177
Year: 2015


Approaches in patients with locally advanced NSCLC: a radiation oncologist's perspective
Source: Eur Respir Monogr 2015; 68: 178-185
Year: 2015


New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Integration of palliative care from the very beginning to the very end in a patient with metastasised non-small cell lung cancer
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


Multimodal therapeutic approach for locally advanced NSCLC in everyday practice
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


Management of early stage lung cancer: a radiation oncologist's perspective
Source: Eur Respir Monogr 2015; 68: 148-158
Year: 2015


Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011